Aurigene Discovery Technologies Limited

This early-phase study tested an experimental oral drug called AUR105 in 17 adults with advanced solid tumors or lymphomas that had come back after prior treatment. The main goals were to check safety, how the drug moves through the body, and find the right dose. The study was te…

This early-stage study tested a new drug called AUR106 in 21 adults with advanced cancers (lung, stomach, bladder, kidney, colon, or esophagus) that had come back or spread. The main goal was to find a safe dose and check how the drug moves through the body. The study was stopped…